Volume 2, Issue 1, Pages 2-4 (July 2002)

Slides:



Advertisements
Similar presentations
Waging War on Cancer with the Sword of Immunity Cell Volume 158, Issue 2, (July 2014) DOI: /j.cell Copyright © 2014 Terms and Conditions.
Advertisements

Direct Evidence of a Role for Heterochromatin in Meiotic Chromosome Segregation Abby F. Dernburg, John W. Sedat, R.Scott Hawley Cell Volume 86, Issue 1,
Lessons from Hereditary Colorectal Cancer
Origins of Metastatic Traits Sakari Vanharanta, Joan Massagué Cancer Cell Volume 24, Issue 4, Pages (October 2013) DOI: /j.ccr
Maintaining Cell Identity through Global Control of Genomic Organization Gioacchino Natoli Immunity Volume 33, Issue 1, Pages (July 2010) DOI: /j.immuni
Cancer Metabolism Cell Volume 148, Issue 3, (February 2012) DOI: /j.cell Copyright © 2012 Terms and Conditions Terms and Conditions.
Double edged sword: pediatric leukemia and the biology of adaptive immunity.
Normal cell cycle DNA replication Doughter cells G2 phase Nuclear division Cytokinesis 1x.
Evolution of the Cancer Stem Cell Model Antonija Kreso, John E. Dick Cell Stem Cell Volume 14, Issue 3, Pages (March 2014) DOI: /j.stem
The Landscape of Microsatellite Instability in Colorectal and Endometrial Cancer Genomes Tae-Min Kim, Peter W. Laird, Peter J. Park Cell Volume 155, Issue.
Cancer Cancer- a malignant tumor; the result of abnormal cell proliferation. Regulation of Cell Division –Tumor Supressor Genes Genes that inhibit cell.
A DNA-Dependent Protease Involved in DNA-Protein Crosslink Repair Julian Stingele, Michael S. Schwarz, Nicolas Bloemeke, Peter G. Wolf, Stefan Jentsch.
Quiescent Hematopoietic Stem Cells Accumulate DNA Damage during Aging that Is Repaired upon Entry into Cell Cycle Isabel Beerman, Jun Seita, Matthew A.
Genetic testing for high-risk colon cancer patients1 William M. Grady Gastroenterology Volume 124, Issue 6, Pages (May 2003) DOI: /S (03)
Chapter 14 GENETIC VARIATION.
Susanne Wingert, Michael A. Rieger  Experimental Hematology 
Resistance in the land of molecular cancer therapeutics
Expanding the Biologist’s Toolkit with CRISPR-Cas9
Shelterin Current Biology
Linking miRNA Regulation to BCR-ABL Expression: The Next Dimension
Genome-editing Technologies for Gene and Cell Therapy
Wild-Type RAS: Keeping Mutant RAS in CHK
DNA repair: Polymerases for passing lesions
Genomic Instability Delayed Genetic Effects.
RAS unplugged: Negative feedback and oncogene-induced senescence
Beyond Making Ends Meet: DNA-PK, Metabolism, and Aging
Cell signaling and cancer
Beyond Making Ends Meet: DNA-PK, Metabolism, and Aging
Designing Effective Hybrid Toxins
Cell fusion: A hidden enemy?
Transcriptional Noise and Somatic Mutations in the Aging Pancreas
Deregulating EMT and Senescence: Double Impact by a Single Twist
Volume 26, Issue 1, Pages 1-2 (July 2014)
Essential Role for Oxidative Phosphorylation in Cancer Progression
Dana Branzei, Marco Foiani  Cell 
Low Rates of Cancer or High-Grade Dysplasia in Colorectal Polyps Collected From Computed Tomography Colonography Screening  Perry J. Pickhardt, Kendra.
DNA-Damage Response in Tissue-Specific and Cancer Stem Cells
A Zygotic Checkpoint for Unrepaired Lesions
Amin S. Herati, M. D. , Boryana H. Zhelyazkova, B. A. , Peter R
Take care of your chromosomes lest cancer take care of you
Circulating tumor DNA: Solid data from liquid biopsies
Liisa Väkevä, Annamari Ranki  Journal of Investigative Dermatology 
Volume 6, Issue 3, Pages (September 2004)
DNA Repair in Prostate Cancer: Biology and Clinical Implications
Ezrin… a metastatic detERMinant?
Volume 3, Issue 4, Pages (April 2003)
A Biomarker Harvest from One Thousand Cancer Cell Lines
Deregulating EMT and Senescence: Double Impact by a Single Twist
CRISPR genome-editing: A medical revolution
Susanne Wingert, Michael A. Rieger  Experimental Hematology 
Genome-editing Technologies for Gene and Cell Therapy
Jean Cadet, Thierry Douki  Journal of Investigative Dermatology 
Volume 141, Issue 1, Pages (July 2011)
Bmi1 and Cell of Origin Determinants of Brain Tumor Phenotype
Telomeres: The Molecular Events Driving End-To-End Fusions
Sietske T. Bakker, Emmanuelle Passegué  Experimental Hematology 
Specific Tumor Suppressor Genes
For MutY, It's All about the OG
The new kid on the block(ade) of the IGF-1 receptor
Volume 10, Issue 3, Pages (September 2006)
Sex Differences in Lifespan
Chromothripsis Current Biology
ATMIN: A New Tumor Suppressor in Developing B Cells
Volume 4, Issue 4, Pages (October 2003)
Epidemiology of Thymoma and Associated Malignancies
Who should decide margin length in pulmonary excision of lung cancer?
The Recombination Hot Spot Chi Is Embedded within Islands of Preferred DNA Pairing Sequences in the E. coli Genome  Robert B Tracy, Frédéric Chédin, Stephen.
Ibrutinib Treatment of CLL: The Cancer Fights Back
Volume 3, Issue 4, Pages (April 2003)
No Driver behind the Wheel? Targeting Transcription in Cancer
Presentation transcript:

Volume 2, Issue 1, Pages 2-4 (July 2002) Functions of p53 suppress critical consequences of damage and repair in the initiation of cancer  Thea D Tlsty  Cancer Cell  Volume 2, Issue 1, Pages 2-4 (July 2002) DOI: 10.1016/S1535-6108(02)00088-0

Figure 1 Generation of complicons In a properly functioning cell (A), the majority of continually produced DNA damage is repaired. The few lesions that avoid repair activate functions of p53 that cause these cells to be cleared from the population. Inadequate removal of damaged DNA can overwhelm the second line of defense (p53), and rare cells with rearrangements survive (B). Finally, in cells that have lost both NHEJ and p53 functions (C), abnormal cells are readily produced and are no longer cleared from the population. These cells continue to proliferate and acquire the genomic changes that allow for malignant outgrowth. Cancer Cell 2002 2, 2-4DOI: (10.1016/S1535-6108(02)00088-0)